Epidermis-targeted gene transfer using in vivo electroporation. 2005

Hiroki Maruyama, and Jun-Ichi Miyazaki, and Fumitake Gejyo
Division of Clinical Nephrology and Rheumatology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.

The skin is an important target for gene transfer because of its easy accessibility. Recently, we demonstrated that an in vivo electroporation approach could be applied to plasmid deoxyribonucleic acid delivery in rat skin of the abdominal area. Plate-and-fork type electrodes were effective for gene delivery by skin-targeted gene transfer. Eight 12-24 V, 50-m electric pulses were delivered through the electrodes. Skin injection with pCAGGS-lacZ showed lacZ gene expression in the upper most cell layers (horny, granular, and prickle cell layers) of the epidermis on day 1 and in the subcutaneous muscle layer on day 7 after the pCAGGS-lacZ transfer. Slight skin damage as the result of the gene transfer procedure was evident on day 1 but absent by day 7. These results demonstrate that plasmid deoxyribonucleic acid transfer by in vivo electro poration at low voltage is a useful procedure for short-term skin-targeted gene transfer.

UI MeSH Term Description Entries
D010957 Plasmids Extrachromosomal, usually CIRCULAR DNA molecules that are self-replicating and transferable from one organism to another. They are found in a variety of bacterial, archaeal, fungal, algal, and plant species. They are used in GENETIC ENGINEERING as CLONING VECTORS. Episomes,Episome,Plasmid
D004817 Epidermis The external, nonvascular layer of the skin. It is made up, from within outward, of five layers of EPITHELIUM: (1) basal layer (stratum basale epidermidis); (2) spinous layer (stratum spinosum epidermidis); (3) granular layer (stratum granulosum epidermidis); (4) clear layer (stratum lucidum epidermidis); and (5) horny layer (stratum corneum epidermidis).
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001616 beta-Galactosidase A group of enzymes that catalyzes the hydrolysis of terminal, non-reducing beta-D-galactose residues in beta-galactosides. Deficiency of beta-Galactosidase A1 may cause GANGLIOSIDOSIS, GM1. Lactases,Dairyaid,Lactaid,Lactogest,Lactrase,beta-D-Galactosidase,beta-Galactosidase A1,beta-Galactosidase A2,beta-Galactosidase A3,beta-Galactosidases,lac Z Protein,Protein, lac Z,beta D Galactosidase,beta Galactosidase,beta Galactosidase A1,beta Galactosidase A2,beta Galactosidase A3,beta Galactosidases
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus
D018274 Electroporation A technique in which electric pulses, in kilovolts per centimeter and of microsecond-to-millisecond duration, cause a loss of the semipermeability of CELL MEMBRANES, thus leading to ion leakage, escape of metabolites, and increased uptake by cells of drugs, molecular probes, and DNA. Depending on the dosage, the formation of openings in the cell membranes caused by the electric pulses may or may not be reversible. Electric Field-Mediated Cell Permeabilization,Irreversible Electroporation,Reversible Electroporation,Electropermeabilisation,Electric Field Mediated Cell Permeabilization,Electroporation, Irreversible,Electroporation, Reversible

Related Publications

Hiroki Maruyama, and Jun-Ichi Miyazaki, and Fumitake Gejyo
March 2005, Expert opinion on drug delivery,
Hiroki Maruyama, and Jun-Ichi Miyazaki, and Fumitake Gejyo
January 2021, Methods in molecular biology (Clifton, N.J.),
Hiroki Maruyama, and Jun-Ichi Miyazaki, and Fumitake Gejyo
December 2013, Journal of insect physiology,
Hiroki Maruyama, and Jun-Ichi Miyazaki, and Fumitake Gejyo
January 2020, Methods in molecular biology (Clifton, N.J.),
Hiroki Maruyama, and Jun-Ichi Miyazaki, and Fumitake Gejyo
September 1998, Nature biotechnology,
Hiroki Maruyama, and Jun-Ichi Miyazaki, and Fumitake Gejyo
January 2002, Methods in molecular medicine,
Hiroki Maruyama, and Jun-Ichi Miyazaki, and Fumitake Gejyo
March 2001, Neuron,
Hiroki Maruyama, and Jun-Ichi Miyazaki, and Fumitake Gejyo
May 2004, Biochemical and biophysical research communications,
Hiroki Maruyama, and Jun-Ichi Miyazaki, and Fumitake Gejyo
December 2001, Developmental biology,
Hiroki Maruyama, and Jun-Ichi Miyazaki, and Fumitake Gejyo
April 2005, Gene therapy,
Copied contents to your clipboard!